Lipid peroxides in type 2 diabetic patients with neuropathy

Research Communications in Molecular Pathology and Pharmacology

Volumn 117-118, Issue , 2005, Pages 5-12

  Migdalis, I N ^a   Triantafilou, P ^a   Petridou, E ^a   Varvarigos, N ^a   Totolos, V ^a   Rigopoulos, A ^a  

^a NIMTS HOSPITAL   (Greece)

Author keywords

Free radicals; Lipid peroxides; Neuropathy; TBARS; Type 2 diabetes

Indexed keywords

FREE RADICAL; GLUCOSE; HEMOGLOBIN A1C; LIPID PEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; AGED; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC NEUROPATHY; FEMALE; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; NERVE INJURY; NEUROBIOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

AGED; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; HUMANS; LIPID PEROXIDES; MALE; MIDDLE AGED; NEURAL CONDUCTION; PAIN THRESHOLD; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 40549097767     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Collier, A., Rumley, A., Rumley, A.G., Paterson, J.R., Leach, J.P., Lowe, C.D. and Small, M. (1992): Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria. Diabetes 44: 909-913.
2. Dominguez, C., Ruiz, E., Gussinye, M. and Carrascosa A. (1998): Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Diabetes Care 21: 1736-1742.
3. Feldman, E.L., Stevens, M.J., Thomas, P.K., Brown, M.B., Canal, N. and Greene, D.A. (1994): A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17: 1281-1289.
4. Hendriks, T. and Assmann, R.F.T.A. (1988): On the fluorometric assay of circulating lipoperoxides. Clin. Chim. Acta. 174: 263-270.
5. Jain, S.K., Krueger, K.S., McVie, R., Jaramillo, J.J., Palmer, M. and Smith, T. (1998): Relationship of blood thromboxane - B2 (TxB2) with lipid peroxides and effect of vitamin E and placebo supplementation on TxB2 and lipid peroxide levels in type 1 diabetic patients. Diabetes Care 21: 1511-1516.
6. Jaynes, P.K., Willis, M.C. and Chou, P.P. (1985): Evaluation of a mini-column chromatographic procedure for the measurement of hemoglobin. Aic. Clin. Chem. 23: 882-884.
7. Kalogeropoulou, K., Mortzos, G., Migdalis, I., Velentzas, C., Mikhailidis, D., Georgiadis, E. and Cordopatis, P. (2002): Carotid atherosclerosis in Type 2 diabetes mellitus: Potential Role of Endothelin-1, Lipoperoxides and Prostacyclin. Antiology 53: 279-285.
8. Kennedy, W.R., Wendelschafer-Crabb, G. and Johnson, T. (1996): Quantitation of epidermal nerves in diabetic neuropathy. Neurology 47: 1042-1048.
9. Low, P.A. and Nickander, K.K. (1991): Oxygen free radical effects in sciatic nerve in experimental diabetes. Diabetes 40: 873-877.
10. Low, P.A., Nickander, K.K. and Tritschler, H.J. (1997): The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 46 (suppl.2): 38-42.
11. Low, P.A. (2003): Oxidative stress: an integrative view. In: Textbook of Diabetic Neuropathy. Edited by Gries, F.A., Cameron, N.E., Low, P.A. and Ziegler, D. Thiem, Stuttgart, pp. 123-128.
12. Migdalis, I.N., Kalogeropoulou, K., Kalantzis, L., Nounopoulos, C., Bouloukos, A. and Samartzis M. (1995): Insulin-like growth factor-1 and IGF-1 receptors in diabetic patients with neuropathy. Diabetic Med 12: 823-827.
13. Migdalis, I.N., Xenos, K., Chairopoulos, K., Varvarigos, N., Leontiades, E. and Karmaniolas K. (2000): Ca2+-Mg2+-ATPase activity and ionized calcium in Type 2 diabetic patients with neuropathy. Diab. Res. Clin. Pract. 54: 129-136.
14. Migdalis, I.N., Kalogeropoulou, K., Iliopoulou, V., Varvarigos, N., Karmaniolas, K.D., Mortzos, G. and Cordopatis P. (2000): Progression of carotid atherosclerosis and the role of endothelin in diabetic patients. Res. Com. Mol. Path. Pharm. 108: 27-37.
15. Migdalis I.N., Kalogeropoulou, K., Iliopoulou, V., Triantafilou, P., Charalabides, J., Mortzos, G. and Cordopatis C. (2001): Plasma levels of endothelin, lipid peroxides and prostacyclin in diabetic patients with macroangiopathy. Diab. Res. Clin. Pract. 54: 129-136.
16. Migdalis, I.N. (2002): Cytocines and diabetes mellitus: a review. Res. Com. Mol. Path. Pharm. 111: 115-138.
17. Nuttall, S.L., Dunne, F., Kendall, M.J. and Martin, U. (1999). Age-independent oxidative stress in elderly patients with non-insulin-dependent diabetes mellitus. Q. J. Med. 92: 33-38.
18. Romero, F.J., Segura-Aguilar, J., Mousalve, E., Hermenegildo, C., Nies, E., Puertas, F.J. and Roma, J. (1990): Antioxidant and gluthione-related enzymatic activities in rat sciatic nerve. Neurotoxical Teratol 12: 603-605.
19. Romero, F.J., Monsalve, E., Hermenegildo, C., Puertas, F.J., Higueras, V., Nies, E., Segura-Aguilar, J. and Roma, J. (1991): Oxygen toxicity in the nervous tissue: comparison of the antioxidant defense of rat brain and sciatic nerve. Neurochem. Res. 16: 157-161.
20. Sato, Y., Hotta, N., Sakamoto, N., Matsuoka, S., Otinishi, N. and Yagi, K. (1979): Lipid peroxide level in plasma of diabetic patients. Biochem. J. 21: 104-107.
21. Stevens, M.J., Feldman, E.L., Thomas, P.K. and Greene, D.A. (1988): Pathogenesis of diabetic neuropathy. In: Management of Diabetic Neuropathy. Edited by Veves, A. Humana Press, Totowa NJ., pp. 13-48.
22. Velazquez, E., Winocour, P.H., Kesteven, P., Alberti, K.G.M.M. and Laker, M.F. (1991): Relation of lipid peroxides to Macrovascular disease in Type 2 diabetes. Diabetic Med. 8: 752-758.